Creative Balloons has successfully closed €15 million in growth financing to enhance its operations, backed by leading German venture capitalists.

Target Information

Creative Balloons is an innovative company operating in the medical technology sector. The firm specializes in the development of advanced solutions aimed at improving patient care through the use of specialized balloon technologies.

Recently, Creative Balloons announced the successful closure of €15 million in growth financing, which marks a significant milestone in the company's expansion plans. This funding will enable the company to enhance its product offerings and expand its market reach.

Industry Overview in Germany

The medical technology industry in Germany is one of the most robust sectors in Europe, supported by the country’s strong engineering foundation and investment

View Source

Similar Deals

Holland Capital Semalytix

2025

Growth Equity & Expansion Capital Proprietary & Advanced Pharmaceuticals Germany
WMS ROTOP Pharmaka GmbH

2025

Growth Equity & Expansion Capital Proprietary & Advanced Pharmaceuticals Germany
GENUI and SHS Capital ROTOP Pharmaka GmbH

2025

Growth Equity & Expansion Capital In-Vivo Diagnostic & Testing Substances Germany
Great Point Partners Lyocontract GmbH

2024

Growth Equity & Expansion Capital Pharmaceuticals (NEC) Germany
BONVENTURE, Ship2B Ventures ViViRA

2024

Growth Equity & Expansion Capital Telemedicine Services Germany
ARCHIMED PlasmidFactory

2023

Growth Equity & Expansion Capital Biotechnology & Medical Research (NEC) Germany

Wellington Partners, MIG Fonds, Salvia

invested in

Creative Balloons

in 2021

in a Growth Equity & Expansion Capital deal

Disclosed details

Transaction Size: $18M

Deal Parameters
Industry
Country
Seller type

Sign Up to Dealert